BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Szabo A. Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities. Front Immunol 2015;6:358. [PMID: 26236313 DOI: 10.3389/fimmu.2015.00358] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Barnett BS, Greer GR. Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer. J Acad Consult Liaison Psychiatry 2021;62:460-71. [PMID: 34210406 DOI: 10.1016/j.jaclp.2020.12.011] [Reference Citation Analysis]
2 Sun X, Liu Y, Yang Y, Liu X, Xiang D. Anti-arthritic effect of total saponins from Clematis henryi Oliv . on collagen-induced arthritis rats. Eur J Inflamm 2016;14:71-7. [DOI: 10.1177/1721727x16644448] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 Uthaug MV, Lancelotta R, Szabo A, Davis AK, Riba J, Ramaekers JG. Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment. Psychopharmacology (Berl) 2020;237:773-85. [PMID: 31822925 DOI: 10.1007/s00213-019-05414-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
4 Lee ES, Lee MY, Kwon MH, Kim HM, Kang JS, Kim YM, Lee EY, Chung CH. Sarpogrelate hydrochloride ameliorates diabetic nephropathy associated with inhibition of macrophage activity and inflammatory reaction in db/db mice. PLoS One 2017;12:e0179221. [PMID: 28640832 DOI: 10.1371/journal.pone.0179221] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
5 Szabo A, Kovacs A, Riba J, Djurovic S, Rajnavolgyi E, Frecska E. The Endogenous Hallucinogen and Trace Amine N,N-Dimethyltryptamine (DMT) Displays Potent Protective Effects against Hypoxia via Sigma-1 Receptor Activation in Human Primary iPSC-Derived Cortical Neurons and Microglia-Like Immune Cells. Front Neurosci 2016;10:423. [PMID: 27683542 DOI: 10.3389/fnins.2016.00423] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
6 Earp BD. Psychedelic Moral Enhancement. Roy Inst Philos Suppl 2018;83:415-39. [DOI: 10.1017/s1358246118000474] [Cited by in Crossref: 9] [Article Influence: 2.3] [Reference Citation Analysis]
7 Uthaug MV, Lancelotta R, Ortiz Bernal AM, Davis AK, Ramaekers JG. A comparison of reactivation experiences following vaporization and intramuscular injection (IM) of synthetic 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting. Journal of Psychedelic Studies 2020;4:104-13. [DOI: 10.1556/2054.2020.00123] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Thompson C, Szabo A. Psychedelics as a novel approach to treating autoimmune conditions. Immunol Lett 2020;228:45-54. [PMID: 33035575 DOI: 10.1016/j.imlet.2020.10.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
9 Rodrigues AV, Almeida FJ, Vieira-coelho MA. Dimethyltryptamine: Endogenous Role and Therapeutic Potential. Journal of Psychoactive Drugs 2019;51:299-310. [DOI: 10.1080/02791072.2019.1602291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
10 Hamill J, Hallak J, Dursun SM, Baker G. Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness. Curr Neuropharmacol 2019;17:108-28. [PMID: 29366418 DOI: 10.2174/1570159X16666180125095902] [Cited by in Crossref: 32] [Cited by in F6Publishing: 15] [Article Influence: 10.7] [Reference Citation Analysis]
11 Chan YL, Lai WC, Chen JS, Tseng JT, Chuang PC, Jou J, Lee CT, Sun HS. TIAM2S Mediates Serotonin Homeostasis and Provokes a Pro-Inflammatory Immune Microenvironment Permissive for Colorectal Tumorigenesis. Cancers (Basel) 2020;12:E1844. [PMID: 32650570 DOI: 10.3390/cancers12071844] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Cozzi NV, Daley PF. Synthesis and characterization of high-purity N,N-dimethyltryptamine hemifumarate for human clinical trials. Drug Test Anal 2020;12:1483-93. [PMID: 32608093 DOI: 10.1002/dta.2889] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Bornemann J, Close JB, Spriggs MJ, Carhart-Harris R, Roseman L. Self-Medication for Chronic Pain Using Classic Psychedelics: A Qualitative Investigation to Inform Future Research. Front Psychiatry 2021;12:735427. [PMID: 34867525 DOI: 10.3389/fpsyt.2021.735427] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Nichols DE. Psychedelics. Pharmacol Rev. 2016;68:264-355. [PMID: 26841800 DOI: 10.1124/pr.115.011478] [Cited by in Crossref: 416] [Cited by in F6Publishing: 326] [Article Influence: 69.3] [Reference Citation Analysis]
15 Heuschkel K, Kuypers KPC. Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Review. Front Psychiatry 2020;11:224. [PMID: 32296353 DOI: 10.3389/fpsyt.2020.00224] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
16 Vilca-Melendez S, Uthaug MV, Griffin JL. 1H Nuclear Magnetic Resonance: A Future Approach to the Metabolic Profiling of Psychedelics in Human Biofluids? Front Psychiatry 2021;12:742856. [PMID: 34966300 DOI: 10.3389/fpsyt.2021.742856] [Reference Citation Analysis]
17 Simonsson O, Osika W, Carhart-Harris R, Hendricks PS. Associations between lifetime classic psychedelic use and cardiometabolic diseases. Sci Rep 2021;11:14427. [PMID: 34257396 DOI: 10.1038/s41598-021-93787-4] [Reference Citation Analysis]
18 Dean JG. Indolethylamine-N-methyltransferase Polymorphisms: Genetic and Biochemical Approaches for Study of Endogenous N,N,-dimethyltryptamine. Front Neurosci 2018;12:232. [PMID: 29740267 DOI: 10.3389/fnins.2018.00232] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
19 Simonsson O, Hendricks PS, Carhart-Harris R, Kettner H, Osika W. Association Between Lifetime Classic Psychedelic Use and Hypertension in the Past Year. Hypertension 2021;77:1510-6. [PMID: 33677982 DOI: 10.1161/HYPERTENSIONAHA.120.16715] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Elman I, Pustilnik A, Borsook D. Beating Pain with Psychedelics: Matter over Mind? Neurosci Biobehav Rev 2021:S0149-7634(21)00553-4. [PMID: 34922987 DOI: 10.1016/j.neubiorev.2021.12.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
21 Schindler EAD, Wallace RM, Sloshower JA, D'Souza DC. Neuroendocrine Associations Underlying the Persistent Therapeutic Effects of Classic Serotonergic Psychedelics. Front Pharmacol 2018;9:177. [PMID: 29545753 DOI: 10.3389/fphar.2018.00177] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
22 Matzopoulos R, Morlock R, Morlock A, Lerer B, Lerer L. Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health Outcomes. Front Psychiatry 2022;12:780696. [DOI: 10.3389/fpsyt.2021.780696] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Rainville JR, Tsyglakova M, Hodes GE. Deciphering sex differences in the immune system and depression. Front Neuroendocrinol 2018;50:67-90. [PMID: 29288680 DOI: 10.1016/j.yfrne.2017.12.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
24 Schindler EAD, Sewell RA, Gottschalk CH, Luddy C, Flynn LT, Lindsey H, Pittman BP, Cozzi NV, D'Souza DC. Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin. Neurotherapeutics 2021;18:534-43. [PMID: 33184743 DOI: 10.1007/s13311-020-00962-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
25 Poulie CBM, Jensen AA, Halberstadt AL, Kristensen JL. DARK Classics in Chemical Neuroscience: NBOMes. ACS Chem Neurosci 2019. [PMID: 31657895 DOI: 10.1021/acschemneuro.9b00528] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
26 Frecska E, Bokor P, Winkelman M. The Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of Civilization. Front Pharmacol 2016;7:35. [PMID: 26973523 DOI: 10.3389/fphar.2016.00035] [Cited by in Crossref: 77] [Cited by in F6Publishing: 54] [Article Influence: 12.8] [Reference Citation Analysis]
27 Borbély E, Varga V, Szögi T, Schuster I, Bozsó Z, Penke B, Fülöp L. Impact of Two Neuronal Sigma-1 Receptor Modulators, PRE084 and DMT, on Neurogenesis and Neuroinflammation in an Aβ1-42-Injected, Wild-Type Mouse Model of AD. Int J Mol Sci 2022;23:2514. [PMID: 35269657 DOI: 10.3390/ijms23052514] [Reference Citation Analysis]
28 Germann CB. 5-Methoxy-N,N-dimethyltryptamine: An Ego-Dissolving Endogenous Neurochemical Catalyst of Creativity. Act Nerv Super 2019;61:170-216. [DOI: 10.1007/s41470-019-00063-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Dakic V, Minardi Nascimento J, Costa Sartore R, Maciel RM, de Araujo DB, Ribeiro S, Martins-de-Souza D, Rehen SK. Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT. Sci Rep 2017;7:12863. [PMID: 28993683 DOI: 10.1038/s41598-017-12779-5] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 7.6] [Reference Citation Analysis]
30 Kelly JR, Crockett MT, Alexander L, Haran M, Baker A, Burke L, Brennan C, O'Keane V. Psychedelic science in post-COVID-19 psychiatry. Ir J Psychol Med 2021;38:93-8. [PMID: 32811575 DOI: 10.1017/ipm.2020.94] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Gainetdinov RR, Hoener MC, Berry MD. Trace Amines and Their Receptors.Pharmacol Rev. 2018;70:549-620. [PMID: 29941461 DOI: 10.1124/pr.117.015305] [Cited by in Crossref: 98] [Cited by in F6Publishing: 82] [Article Influence: 24.5] [Reference Citation Analysis]
32 Simonsson O, Sexton JD, Hendricks PS. Associations between lifetime classic psychedelic use and markers of physical health. J Psychopharmacol 2021;35:447-52. [PMID: 33719688 DOI: 10.1177/0269881121996863] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Park I, Byun HS, Hur GM, Na M. Tulipiferamide A, an Alkamide from Liriodendron tulipifera, Exhibits an Anti-Inflammatory Effect via Targeting IKKβ Phosphorylation. J Nat Prod 2021;84:1598-606. [PMID: 33939429 DOI: 10.1021/acs.jnatprod.1c00146] [Reference Citation Analysis]
34 Szabo A, Frecska E. Dimethyltryptamine (DMT): a biochemical Swiss Army knife in neuroinflammation and neuroprotection? Neural Regen Res 2016;11:396-7. [PMID: 27127466 DOI: 10.4103/1673-5374.179041] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
35 Saeger HN, Olson DE. Psychedelic-inspired approaches for treating neurodegenerative disorders. J Neurochem 2021. [PMID: 34816433 DOI: 10.1111/jnc.15544] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Szabo A, Gogolak P, Koncz G, Foldvari Z, Pazmandi K, Miltner N, Poliska S, Bacsi A, Djurovic S, Rajnavolgyi E. Immunomodulatory capacity of the serotonin receptor 5-HT2B in a subset of human dendritic cells. Sci Rep 2018;8:1765. [PMID: 29379077 DOI: 10.1038/s41598-018-20173-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 7.5] [Reference Citation Analysis]
37 Jiménez JH, Bouso JC. Significance of mammalian N, N-dimethyltryptamine (DMT): A 60-year-old debate. J Psychopharmacol 2022;:2698811221104054. [PMID: 35695604 DOI: 10.1177/02698811221104054] [Reference Citation Analysis]
38 Ahsan H, Irfan HM, Alamgeer, Shahzad M, Asim MH, Akram M, Zafar MS. Anti-rheumatic activity of pseudoephedrine (a substituted phenethylamine) in complete Freund's adjuvant-induced arthritic rats by down regulating IL-1β, IL-6 and TNF-α as well as upregulating IL-4 and IL-10. Inflammopharmacology 2021;29:673-82. [PMID: 33772383 DOI: 10.1007/s10787-021-00804-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Kelly JR, Gillan CM, Prenderville J, Kelly C, Harkin A, Clarke G, O'Keane V. Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective. Front Psychiatry 2021;12:800072. [PMID: 34975593 DOI: 10.3389/fpsyt.2021.800072] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
40 Lowe H, Toyang N, Steele B, Grant J, Ali A, Gordon L, Ngwa W. Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders. Molecules 2022;27:2520. [DOI: 10.3390/molecules27082520] [Reference Citation Analysis]
41 Kozlowska U, Nichols C, Wiatr K, Figiel M. From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders. J Neurochem 2021. [PMID: 34519052 DOI: 10.1111/jnc.15509] [Reference Citation Analysis]